09:13 AM EDT, 08/07/2024 (MT Newswires) -- SpringWorks Therapeutics ( SWTX ) reported a Q2 loss Wednesday of $0.54 per diluted share, narrower than the $1.25 per share loss a year earlier.

Analysts surveyed by Capital IQ expected a loss of $1.12 per share.

Revenue for the quarter ended June 30 was $59.7 million. No revenue was reported a year earlier.

Analysts surveyed by Capital IQ expected $34.6 million.

SpringWorks shares were more than 11% higher in recent premarket activity.

Price: 37.00, Change: +3.78, Percent Change: +11.38